High throughput virtual screening and validation of Plant-Based EGFR L858R kinase inhibitors against Non-Small cell lung Cancer: An integrated approach Utilizing GC-MS, network Pharmacology, Docking, and molecular dynamics

被引:1
|
作者
Gao, Kun [1 ]
Chen, Zujian [2 ]
Zhang, Na [3 ]
Jiang, Pu [1 ]
机构
[1] Hebei Med Univ, Thorac Surg Dept, Hosp 4, 12 Jiankang Rd, Shijiazhuang 050000, Hebei, Peoples R China
[2] Linxi Cty Peoples Hosp, Xingtai City Linxi Cty Peoples Hosp New Campus, Thorac Surg Dept, Shijiazhuang 054900, Peoples R China
[3] Hebei Med Univ, Dept Radiat Oncol, Hosp 4, 1,2 Jiankang Rd, Shijiazhuang 050000, Hebei, Peoples R China
关键词
EGFR; A549; Vero; NSCLC; Network Pharmacology; ADMET; Docking; GC-MS; Molecular Dynamics; DFT; Virtual Screening and Selectivity index; ANTICANCER ACTIVITY; LACTONE; DEATH;
D O I
10.1016/j.jsps.2024.102139
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Lung cancer ranks as the 2nd most common cancer globally. It's the most prevalent cancer in men and the 2nd most common in women. The prominent events in EGFR-mutated non-small-cell lung cancer (NSCLC) include the emergence of the L858R mutation within EGFR exon 21. Despite the promising efficacy of EGFR inhibitors in managing lung cancer, the development of acquired resistance poses a significant hurdle. In the current investigation, we focused on the screening of two phytochemicals, namely Dehydrocostus lactone and Mokkolactone, derived from the Saussurea lappa plant, as potential inhibitors targeting EGFR L858R mutant lung cancer. The chloroform and ethanol extract of the plant demonstrated anti-proliferative activity through the Resazurin chemosensitivity assay, exhibiting an IC50 value of 37.90 f 0.29 mu g/ml with selectivity index 2.4. Through a GC-MS study, we identified 11 phytochemicals for further insilico analysis. These compounds underwent ADMET assessment followed by drug likeliness analysis before being subjected to molecular docking against EGFR L858R, identified through protein-protein interaction network analysis. All phytochemicals exhibited binding energy scores ranging from-6.9 to-8.1 kcal/mol. Dehydrocostus lactone and Mokkolactone were specifically identified for their binding profile. Findings from 100 ns molecular dynamics simulations demonstrated their enhanced stability compared to the reference ligand DJK. This was evident in the root mean square deviation (RMSD) values, ranging from 0.23 f 0.01 nm to 0.30 f 0.05 nm, the radius of gyration values, from 1.71 f 0.01 nm to 1.72 f 0.01 nm, and the solvent accessible surface area values, from 155.39 f 2.40 nm2 2 to 159.32 f 2.14 nm2. 2 . Additionally, favourable characteristics were observed in terms of hydrogen bonding, principal component analysis, and free energy landscape analysis. Examination of their electronic structure via density functional theory revealed efficient properties, with the highest occupied molecular orbital-least unoccupied molecular orbital energy gap values ranging from-3.984 eV to-6.547 eV. Further, in vivo analysis is required to gain a more comprehensive understanding and efficacy of these identified phytochemicals against lung cancer.
引用
收藏
页数:14
相关论文
共 12 条
  • [1] EGFR tyrosine kinase inhibitors versus chemotherapy as first-line therapy for non-small cell lung cancer patients with the L858R point mutation
    Jianlin Xu
    Haitang Yang
    Bo Jin
    Yuqing Lou
    Yanwei Zhang
    Xueyan Zhang
    Hua Zhong
    Huiming Wang
    Dan Wu
    Baohui Han
    Scientific Reports, 6
  • [2] EGFR tyrosine kinase inhibitors versus chemotherapy as first-line therapy for non-small cell lung cancer patients with the L858R point mutation
    Xu, Jianlin
    Yang, Haitang
    Jin, Bo
    Lou, Yuqing
    Zhang, Yanwei
    Zhang, Xueyan
    Zhong, Hua
    Wang, Huiming
    Wu, Dan
    Han, Baohui
    SCIENTIFIC REPORTS, 2016, 6
  • [3] Correction: Corrigendum: EGFR tyrosine kinase inhibitors versus chemotherapy as first-line therapy for non-small cell lung cancer patients with the L858R point mutation
    Jianlin Xu
    Haitang Yang
    Bo Jin
    Yuqing Lou
    Yanwei Zhang
    Xueyan Zhang
    Hua Zhong
    Huiming Wang
    Dan Wu
    Baohui Han
    Scientific Reports, 6
  • [4] Novel EGFR inhibitors against resistant L858R/T790M/C797S mutant for intervention of non-small cell lung cancer
    Wang, Xiaoxue
    Qin, Zhongxiang
    Qiu, Wenrui
    Xu, Kejia
    Bai, Yuting
    Zeng, Beilei
    Ma, Yakun
    Yang, Shuang
    Shi, Yi
    Fan, Yan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 277
  • [5] Elucidating the anti-cancer potential of Cinnamomum tamala essential oil against non-small cell lung cancer: A multifaceted approach involving GC-MS profiling, network pharmacology, and molecular dynamics simulations
    Mohanty, Debajani
    Padhee, Sucheesmita
    Priyadarshini, Arpita
    Champati, Bibhuti Bhusan
    Das, Prabhat Kumar
    Jena, Sudipta
    Sahoo, Ambika
    Panda, Pratap Chandra
    Nayak, Sanghamitra
    Ray, Asit
    HELIYON, 2024, 10 (06)
  • [6] High throughput virtual screening of phosphodiesterase type-5 (PDE-5) inhibitors against erectile dysfunction from Saussurea lappa roots: An integrated approach utilizing GC-MS, machine learning, docking, molecular dynamics, and DFT based analysis
    Mu, Ying
    Ru, Feng
    Li, Chunfeng
    JOURNAL OF MOLECULAR STRUCTURE, 2025, 1333
  • [7] Molecular mechanisms of phytoconstituents from selected Egyptian plants against non-small cell lung cancer using integrated in vitro network pharmacology and molecular docking approach
    Shaala, Lamiaa A.
    Youssef, Diaa T. A.
    Ramadan, Mahmoud A.
    Khalifa, Azza A.
    Ibrahim, Reham S.
    Valeriote, Fred
    Celik, Ismail
    Dawood, Hend M.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025,
  • [8] Efficacy of EGFR tyrosine kinase inhibitors in patients with EGFR-mutated non-small cell lung cancer except both exon 19 deletion and exon 21 L858R: A retrospective analysis in Korea
    Baek, Jin Ho
    Sun, Jong-Mu
    Min, Young Joo
    Cho, Eun Kyung
    Cho, Byoung Chul
    Kim, Joo-Hang
    Ahn, Myung-Ju
    Park, Keunchil
    LUNG CANCER, 2015, 87 (02) : 148 - 154
  • [9] Molecular docking and dynamics based approach for the identification of kinase inhibitors targeting PI3Kα against non-small cell lung cancer: a computational study
    Halder, Debojyoti
    Das, Subham
    Aiswarya, R.
    Jeyaprakash, R. S.
    RSC ADVANCES, 2022, 12 (33) : 21452 - 21467
  • [10] EGFR tyrosine kinase inhibitors versus chemotherapy as first-line therapy for non-small cell lung cancer patients with the L858R point mutation (vol 6, 36371, 2016)
    Xu, Jianlin
    Yang, Haitang
    Jin, Bo
    Lou, Yuqing
    Zhang, Yanwei
    Zhang, Xueyan
    Zhong, Hua
    Wang, Huiming
    Wu, Dan
    Han, Baohui
    SCIENTIFIC REPORTS, 2016, 6